Suppr超能文献

新冠疫情期间的乳糜泻:HLA 具有保护作用吗?

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

出版信息

Ann Med. 2022 Dec;54(1):617-621. doi: 10.1080/07853890.2022.2039955.

Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and susceptibility to viruses, such as SARS-CoV. In our study, we examined a population of coeliac subjects presenting the HLA haplotype DQ2 and/or DQ8. Our aim was to evaluate whether HLA DQ2 and/or DQ8 haplotype play a role in SARS-CoV-2-infection. The aim was also to evaluate the difficulty in following the gluten-free diet due to all the adversities produced by the pandemic, such as the food supply disruption, and the difficulties in managing the clinical follow-up.

METHODS

191 consecutive coeliac patients completed a questionnaire on their current clinical status, psychological effects, and management of the gluten-free diet experienced during the COVID-19 pandemic and questions regarding possible SARS-CoV-2 infection.

RESULTS

Out of the 191 patients who participated in the study, 42 were full-blown coeliac and 149 were in remission. From the answers provided, 84.8% of patients declared that they no longer consider themselves vulnerable to COVID-19 as they suffer from coeliac disease; 94.2% of patients did not encounter any difficulties in managing the gluten-free diet or in acquiring specific foods and 64.9% of patients in our study underwent diagnostic testing for SARS-CoV-2. Out of this number, 31.5% did so due to contacts with subjects affected by COVID-19, 26.6% for work related reasons, 11.3% due to flu-like symptoms and 30.6% for other reasons. Only 5.8% of the enrolled patients received a diagnosis of COVID-19. Out of all the patients in our population who were diagnosed with COVID-19, 94.8% developed no symptoms and none of them needed hospitalization or intensive care.

CONCLUSION

The hypothesis that the HLADQ2 and/or DQ8 haplotype plays a protective role against SARS-CoV-2 infection, as against other viral infections, is intriguingly suggestive.KEY MESSAGESCOVID-19 as a public health emergency;SARS-CoV-2 and possible complications in coeliac disease;Role of HLA DQ2 and/or DQ8 in SARS-CoV-2 infection.

摘要

背景

新型冠状病毒(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)是一种急性呼吸道疾病,正在成为全球公共卫生紧急事件。几项科学研究报告称,人类白细胞抗原(HLA)多态性与病毒易感性之间存在潜在相关性,例如 SARS-CoV。在我们的研究中,我们检查了一组携带 HLA 单体型 DQ2 和/或 DQ8 的乳糜泻患者。我们的目的是评估 HLA DQ2 和/或 DQ8 单体型是否在 SARS-CoV-2 感染中起作用。我们的目的还在于评估由于大流行带来的所有困难(例如食物供应中断)以及管理临床随访的困难,而导致坚持无麸质饮食的难度。

方法

191 例乳糜泻患者完成了一份关于他们当前临床状况、心理影响以及 COVID-19 大流行期间无麸质饮食管理的问卷,以及关于可能的 SARS-CoV-2 感染的问题。

结果

在参加研究的 191 例患者中,42 例为典型乳糜泻,149 例处于缓解期。从提供的答案中,84.8%的患者表示,由于患有乳糜泻,他们不再认为自己容易感染 COVID-19;94.2%的患者在管理无麸质饮食或获取特定食物方面没有遇到任何困难,64.9%的患者在我们的研究中接受了 SARS-CoV-2 的诊断检测。在这些患者中,31.5%是因为与 COVID-19 患者接触,26.6%是因为工作原因,11.3%是因为流感样症状,30.6%是因为其他原因。我们的研究人群中只有 5.8%的患者被诊断为 COVID-19。在我们的研究人群中所有被诊断为 COVID-19 的患者中,94.8%没有出现症状,没有人需要住院或重症监护。

结论

HLA DQ2 和/或 DQ8 单体型对 SARS-CoV-2 感染具有保护作用的假设,就像对其他病毒感染一样,具有很大的暗示性。

关键信息

COVID-19 作为公共卫生紧急事件;SARS-CoV-2 与乳糜泻可能的并发症;HLA DQ2 和/或 DQ8 在 SARS-CoV-2 感染中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验